MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-10-2026
Varex Imaging Corporation Interest Expense 2011-2026 | VREX
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Varex Imaging Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.4 M | -4.2 M | -20.2 M | -4.3 M | 42.1 M | 31.4 M | 21.1 M | 21.7 M | 12.3 M | 1.9 M | 1.2 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 42.1 M | -20.2 M | 8.96 M |
Quarterly Interest Expense Varex Imaging Corporation
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.3 M | - | 1 M | -4 M | -2.8 M | - | -2.9 M | 700 K | 600 K | - | -700 K | 7.3 M | 7.5 M | - | 9.4 M | 11.1 M | 9.9 M | - | 10.6 M | 10.4 M | 5.4 M | 16.9 M | 6.9 M | 4.6 M | - | 15.7 M | 5.1 M | 5.5 M | 5.1 M | 16.5 M | 5.4 M | 5.1 M | 5.5 M | 5.8 M | 4.2 M | 5.5 M | 600 K | 1.3 M | 400 K | 600 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 16.9 M | -4.3 M | 5 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aziyo Biologics
AZYO
|
5.8 M | - | 1.37 % | $ 20.5 M |  USA |
 |
Bruker Corporation
BRKR
|
-38.2 M | $ 39.08 | -1.83 % | $ 5.82 K | USA |
 |
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | USA |
 |
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | USA |
 |
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
549 K | - | - | $ 10.2 M | USA |
 |
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | USA |
 |
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 7.79 | 3.73 % | $ 559 M |  Israel |
 |
FONAR Corporation
FONR
|
347 K | $ 18.49 | -0.38 % | $ 121 M | USA |
 |
AdaptHealth Corp.
AHCO
|
-274 K | $ 9.41 | -2.39 % | $ 1.27 B | USA |
 |
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | USA |
 |
CONMED Corporation
CNMD
|
31.1 M | $ 43.34 | -5.35 % | $ 1.35 B | USA |
 |
IRadimed Corporation
IRMD
|
164 K | $ 104.65 | 0.88 % | $ 1.33 B | USA |
 |
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | USA |
 |
AxoGen
AXGN
|
167 K | $ 29.78 | -2.84 % | $ 1.37 B | USA |
 |
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.18 | -3.05 % | $ 110 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | USA |
 |
Accuray Incorporated
ARAY
|
559 K | $ 0.52 | -5.19 % | $ 53.4 M | USA |
 |
Pulmonx Corporation
LUNG
|
256 K | $ 1.53 | - | $ 59.8 M | USA |
 |
Neovasc
NVCN
|
133 K | - | - | $ 111 M |  Canada |
 |
Medtronic PLC
MDT
|
402 M | $ 96.73 | -1.38 % | $ 124 B | USA |
 |
Align Technology
ALGN
|
7.68 M | $ 182.92 | -3.23 % | $ 13.7 B | USA |
 |
Inari Medical
NARI
|
294 K | - | - | $ 4.23 B | USA |
 |
Butterfly Network
BFLY
|
-13 K | $ 3.73 | -3.37 % | $ 790 M | USA |
 |
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | USA |
 |
EDAP TMS S.A.
EDAP
|
232 K | $ 3.96 | -3.54 % | $ 148 M |  France |
 |
Abbott Laboratories
ABT
|
548 M | $ 113.53 | -0.49 % | $ 198 B | USA |
 |
NuVasive
NUVA
|
-21.4 M | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
-421 K | - | - | $ 217 M | USA |
 |
Orthofix Medical
OFIX
|
8.11 M | $ 13.02 | -2.62 % | $ 516 M |  Curacao |
 |
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
349 M | $ 73.88 | -3.07 % | $ 109 B | USA |
 |
PAVmed
PAVM
|
-10.5 M | $ 9.94 | -0.4 % | $ 71.9 M | USA |
 |
Penumbra
PEN
|
893 K | $ 340.23 | -0.61 % | $ 13.2 B | USA |